BamSEC and AlphaSense Join Forces
Learn More

Artiva Biotherapeutics, Inc.

NASDAQ: ARTV    
Share price (12/23/24): $10.48    
Market cap (12/23/24): $255 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.8
from S-1/A 2 pages Artiva Biotherapeutics, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.7
from S-1/A 15 pages Artiva Biotherapeutics, Inc. 2024 Employee Stock Purchase Plan Adopted by the Board of Directors: July 11, 2024 Approved by the Stockholders: July 11, 2024 Ipo Date: [ ], 2024
12/34/56
EX-10.4
from S-1/A 34 pages Artiva Biotherapeutics, Inc. 2024 Equity Incentive Plan Adopted by the Board of Directors: July 11, 2024 Approved by the Stockholders: July 11, 2024
12/34/56
EX-10.38
from S-1 9 pages Consulting Agreement
12/34/56
EX-10.37
from S-1 7 pages Re: Employment Offer Letter Dear Heather, on Behalf of Artiva Biotherapeutics, Inc. (The “Company”), I Am Pleased to Offer You Employment Under the Terms Set Forth in This Offer Letter Agreement (This “Agreement”). These Employment Terms Will Be Effective as of Your Start Date, Which Will Be on or Around October 22, 2020 (The “Start Date”)
12/34/56
EX-10.36
from S-1 8 pages Re: Employment Offer Letter Dear Neha,
12/34/56
EX-10.35
from S-1 3 pages Amendment No. 1 to Consulting Agreement
12/34/56
EX-10.34
from S-1 9 pages Consulting Agreement
12/34/56
EX-10.33
from S-1 12 pages Re: Separation Agreement Dear Pete: This Letter Sets Forth the Substance of the Separation Agreement (The “Agreement”) That Artiva Biotherapeutics, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition. 1. Separation. Your Employment Termination Date Will Be March 31, 2023 (The “Separation Date”)
12/34/56
EX-10.32
from S-1 10 pages 3/28/2023 Michael Faerm Re: Separation Agreement Dear Mike: This Letter Sets Forth the Substance of the Separation Agreement (The “Agreement”) That Artiva Biotherapeutics, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition. 1. Separation. Your Employment Termination Date Will Be March 31, 2023 (The “Separation Date”)
12/34/56
EX-10.31
from S-1 2 pages Amendment No. 1 to Consulting Agreement
12/34/56
EX-10.30
from S-1 9 pages Consulting Agreement
12/34/56
EX-10.29
from S-1 9 pages Private & Confidential
12/34/56
EX-10.28
from S-1 3 pages Amendment No. 2 to Strategic Collaboration Agreement
12/34/56
EX-10.27
from S-1 2 pages First Amendment to Collaboration Agreement
12/34/56
EX-10.26
from S-1 65 pages Collaboration Agreement
12/34/56
EX-10.25
from S-1 26 pages Selected Product License Agreement
12/34/56
EX-10.24
from S-1 3 pages First Amendment to License Agreement
12/34/56
EX-10.23
from S-1 15 pages License Agreement
12/34/56
EX-10.22
from S-1 127 pages Lease Agreement
12/34/56